VIVO logo

Meridian Bioscience (VIVO) Net Margin

Annual Net Margin

12.75%
-9.71%-43.23%

September 30, 2022

Summary

Performance

1-Year Change

-43.23%

3-Year Change

+5.11%

5-Year Change

+18.72%

15-Year Change

+18.72%

VIVO Net Margin Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

22.46%
VIVO annual net profit margin is currently -43.23% below its historical high of 22.46%

3-Year Low

12.75%
VIVO annual net profit margin is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Sep 30, 2022
VIVO previous annual earnings announcement was published on Sep 30, 2022

Next Annual Earnings Report Date

N/A
VIVO next annual earnings announcement has not yet been scheduled

OtherVIVOprofitabilitymetrics:

Annual Net Income

$42.46 M
VIVO annual net profit is $42.46 million

Annual Revenue

$333.02 M
VIVO annual revenue is $333.02 million

Annual Gross Margin

56.56%
VIVO annual gross profit margin is 56.56%

Annual EPS

$0.96
VIVO annual earnings per share is $0.96

Quarterly Net Margin

8.69%
+19.52%+180.24%

September 30, 2022

Summary

Performance

3-Month Change

+180.24%

1-Year Change

-0.57%

3-Year Change

+7.68%

5-Year Change

-24.57%

VIVO Quarterly Net Margin Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

32.44%
VIVO quarterly net profit margin is currently -73.21% below its historical high of 32.44%

3-Year Low

-10.83%

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2022
VIVO previous earnings announcement was published on Sep 30, 2022

Next Quarterly Earnings Report Date

N/A
VIVO next earnings announcement has not yet been scheduled

OtherVIVOprofitabilitymetrics:

Quarterly Net Income

$5.71 M
VIVO quarterly net profit is $5.71 million

Quarterly Revenue

$65.67 M
VIVO quarterly revenue is $65.67 million

Quarterly Gross Margin

51.76%
VIVO quarterly gross profit margin is 51.76%

Quarterly EPS

$0.13
VIVO quarterly earnings per share is $0.13

Net Margin Formula

Net Margin =  Net Income
Revenue ✕ 100%

Annual Net Margin

12.75%
VIVO annual net profit margin is 12.75%

Annual Net Income

$42.46 M
VIVO annual net profit is $42.46 million

Annual Revenue

$333.02 M
VIVO annual revenue is $333.02 million

VIVO Net Margin Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-43.2%-0.6%
3 y3 years+5.1%+7.7%
5 y5 years+18.7%-24.6%

VIVO Net Margin Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-43.2%at low-66.4%-224.6%
5 y5-year-43.2%-4.9%-73.2%-224.6%
alltimeall time-43.2%-242.6%-73.2%-718.0%

Meridian Bioscience Net Margin History

DateAnnualQuarterly
Sep 2022
12.75%(-43.2%)
8.69%(-180.2%)
Jun 2022
-
-10.83%(-141.9%)
Mar 2022
-
25.85%(+48.9%)
Dec 2021
-
17.36%(+98.6%)
Sep 2021
22.46%(+23.3%)
8.74%(-52.4%)
Jun 2021
-
18.37%(-40.5%)
Mar 2021
-
30.85%(+7.0%)
Dec 2020
-
28.82%(+184.8%)
Sep 2020
18.21%(+50.1%)
10.12%(-68.8%)
Jun 2020
-
32.44%(+98.7%)
Mar 2020
-
16.33%(+174.0%)
Dec 2019
-
5.96%(-26.1%)
Sep 2019
12.13%(+8.6%)
8.07%(-23.1%)
Jun 2019
-
10.49%(-25.7%)
Mar 2019
-
14.12%(-10.3%)
Dec 2018
-
15.75%(+54.0%)
Sep 2018
11.17%(+4.0%)
10.23%(-22.4%)
Jun 2018
-
13.19%(+40.8%)
Mar 2018
-
9.37%(-22.2%)
Dec 2017
-
12.05%(+4.6%)
Sep 2017
10.74%(-34.7%)
11.52%(+2300.0%)
Jun 2017
-
0.48%(-97.2%)
Mar 2017
-
17.20%(+28.3%)
Dec 2016
-
13.41%(+14.8%)
Sep 2016
16.44%(-9.9%)
11.68%(-32.4%)
Jun 2016
-
17.28%(-2.6%)
Mar 2016
-
17.74%(-5.9%)
Dec 2015
-
18.86%(+4.8%)
Sep 2015
18.24%(-0.9%)
17.99%(-4.7%)
Jun 2015
-
18.88%(-3.4%)
Mar 2015
-
19.54%(+18.7%)
Dec 2014
-
16.46%(-6.1%)
Sep 2014
18.40%(-8.7%)
17.52%(-6.4%)
Jun 2014
-
18.71%(-8.9%)
Mar 2014
-
20.54%(+23.9%)
Dec 2013
-
16.58%(-11.3%)
Sep 2013
20.16%(+4.3%)
18.69%(-13.4%)
Jun 2013
-
21.57%(-0.5%)
Mar 2013
-
21.68%(+16.0%)
Dec 2012
-
18.69%(-5.2%)
Sep 2012
19.32%(+14.4%)
19.72%(-3.8%)
Jun 2012
-
20.50%(+0.6%)
Mar 2012
-
20.38%(+24.2%)
Dec 2011
-
16.41%(-1.0%)
Sep 2011
16.89%(-9.3%)
16.58%(-2.9%)
Jun 2011
-
17.07%(-3.5%)
Mar 2011
-
17.68%(+9.3%)
Dec 2010
-
16.17%(+7.9%)
Sep 2010
18.63%(-15.7%)
14.98%(-21.0%)
Jun 2010
-
18.97%(-1.2%)
Mar 2010
-
19.20%(-8.6%)
Dec 2009
-
21.01%(-0.1%)
Sep 2009
22.09%(+2.1%)
21.03%(-5.4%)
Jun 2009
-
22.23%(+2.0%)
Mar 2009
-
21.79%(-7.5%)
Dec 2008
-
23.55%(+11.8%)
Sep 2008
21.63%(-0.5%)
21.07%(-10.3%)
Jun 2008
-
23.48%(+16.6%)
Mar 2008
-
20.14%(-8.6%)
Dec 2007
-
22.03%(+10.7%)
Sep 2007
21.73%(+28.5%)
19.90%(-32.8%)
Jun 2007
-
29.61%(+61.6%)
Mar 2007
-
18.32%(-5.6%)
Dec 2006
-
19.40%(+16.1%)
Sep 2006
16.91%(+24.4%)
16.71%(-8.6%)
Jun 2006
-
18.29%(+9.5%)
Mar 2006
-
16.71%(+5.0%)
Dec 2005
-
15.91%(+3.8%)
Sep 2005
13.59%(+17.8%)
15.33%(+11.4%)
Jun 2005
-
13.76%(+2.0%)
Mar 2005
-
13.49%(+20.4%)
Dec 2004
-
11.20%(-15.4%)
Sep 2004
11.54%
13.24%(+12.0%)
Jun 2004
-
11.82%(+8.1%)
Mar 2004
-
10.93%(+10.6%)
DateAnnualQuarterly
Dec 2003
-
9.88%(-8.3%)
Sep 2003
10.66%(+25.3%)
10.78%(-7.1%)
Jun 2003
-
11.61%(+2.1%)
Mar 2003
-
11.37%(+28.6%)
Dec 2002
-
8.84%(+59.3%)
Sep 2002
8.51%(-146.8%)
5.55%(-46.8%)
Jun 2002
-
10.44%(+10.6%)
Mar 2002
-
9.44%(+7.8%)
Dec 2001
-
8.76%(+589.8%)
Sep 2001
-18.18%(-246.0%)
1.27%(-127.7%)
Jun 2001
-
-4.59%(-60.6%)
Mar 2001
-
-11.65%(-78.3%)
Dec 2000
-
-53.70%(-489.7%)
Sep 2000
12.45%(+224.2%)
13.78%(+4.9%)
Jun 2000
-
13.14%(+3.6%)
Mar 2000
-
12.68%(+20.9%)
Dec 1999
-
10.49%(-276.3%)
Sep 1999
3.84%(-74.5%)
-5.95%(-173.6%)
Jun 1999
-
8.08%(-8.9%)
Mar 1999
-
8.87%(+72.9%)
Dec 1998
-
5.13%(-60.1%)
Sep 1998
15.06%(-11.7%)
12.86%(-24.7%)
Jun 1998
-
17.07%(-4.6%)
Mar 1998
-
17.89%(+50.3%)
Dec 1997
-
11.90%(-47.2%)
Sep 1997
17.05%(-5.4%)
22.55%(+20.7%)
Jun 1997
-
18.68%(+41.0%)
Mar 1997
-
13.25%(+25.8%)
Dec 1996
-
10.53%(-46.8%)
Sep 1996
18.03%(+29.3%)
19.78%(+0.2%)
Jun 1996
-
19.74%(+2.9%)
Mar 1996
-
19.18%(+75.8%)
Dec 1995
-
10.91%(-33.6%)
Sep 1995
13.94%(+27.2%)
16.42%(+11.6%)
Jun 1995
-
14.71%(+6.2%)
Mar 1995
-
13.85%(+76.7%)
Dec 1994
-
7.84%(-47.5%)
Sep 1994
10.96%(-6.6%)
14.93%(+41.8%)
Jun 1994
-
10.53%(+3.5%)
Mar 1994
-
10.17%(+82.9%)
Dec 1993
-
5.56%(-67.9%)
Sep 1993
11.73%(-3.4%)
17.31%(+148.0%)
Jun 1993
-
6.98%(-45.6%)
Mar 1993
-
12.82%(+79.6%)
Dec 1992
-
7.14%(-58.2%)
Sep 1992
12.14%(+34.7%)
17.07%(+45.2%)
Jun 1992
-
11.76%(+2.9%)
Mar 1992
-
11.43%(+14.3%)
Dec 1991
-
10.00%(-20.0%)
Sep 1991
9.01%(+27.6%)
12.50%(+81.2%)
Jun 1991
-
6.90%(-6.9%)
Mar 1991
-
7.41%(+70.3%)
Dec 1990
-
4.35%(-43.4%)
Sep 1990
7.06%(+45.9%)
7.69%(+69.0%)
Jun 1990
-
4.55%(-9.0%)
Mar 1990
-
5.00%(-15.0%)
Dec 1989
-
5.88%(-5.9%)
Sep 1989
4.84%(+35.6%)
6.25%(-6.3%)
Jun 1989
-
6.67%(0.0%)
Mar 1989
-
6.67%(0.0%)
Dec 1988
-
6.67%(-200.0%)
Sep 1988
3.57%(-62.9%)
-6.67%(-193.4%)
Jun 1988
-
7.14%(+7.0%)
Dec 1987
-
6.67%(-53.3%)
Sep 1987
9.62%(-56.7%)
14.29%(+71.5%)
Jun 1987
-
8.33%(+16.7%)
Mar 1987
-
7.14%(-14.3%)
Dec 1986
-
8.33%(-58.4%)
Sep 1986
22.22%(-1.0%)
20.00%(0.0%)
Jun 1986
-
20.00%(-15.0%)
Mar 1986
-
23.53%(0.0%)
Dec 1985
-
23.53%(+1.9%)
Sep 1985
22.45%
23.08%(-7.7%)
Jun 1985
-
25.00%(0.0%)
Mar 1985
-
25.00%(+50.0%)
Dec 1984
-
16.67%

FAQ

  • What is Meridian Bioscience annual net profit margin?
  • What is the all time high annual net margin for Meridian Bioscience?
  • What is Meridian Bioscience annual net margin year-on-year change?
  • What is Meridian Bioscience quarterly net profit margin?
  • What is the all time high quarterly net margin for Meridian Bioscience?
  • What is Meridian Bioscience quarterly net margin year-on-year change?

What is Meridian Bioscience annual net profit margin?

The current annual net margin of VIVO is 12.75%

What is the all time high annual net margin for Meridian Bioscience?

Meridian Bioscience all-time high annual net profit margin is 22.46%

What is Meridian Bioscience annual net margin year-on-year change?

Over the past year, VIVO annual net profit margin has changed by -9.71% (-43.23%)

What is Meridian Bioscience quarterly net profit margin?

The current quarterly net margin of VIVO is 8.69%

What is the all time high quarterly net margin for Meridian Bioscience?

Meridian Bioscience all-time high quarterly net profit margin is 32.44%

What is Meridian Bioscience quarterly net margin year-on-year change?

Over the past year, VIVO quarterly net profit margin has changed by -0.05% (-0.57%)